- The Company Maintains Fiscal 2026 Guidance -
Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, announced...
Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, announced...
Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, announced...
- Establishes Fiscal 2026 Guidance -
Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, announced...
The S&P 500 Index ($SPX ) (SPY ) on Friday closed up +0.03%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.58%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.34%. March E-mini...